Back

Carotid-Femoral pulse wave velocity progression in hypertensive patients is associated with subsequent cardiovascular outcomes

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Hypertension target organ damage Prevention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Alessandro Maloberti

ASST Great Metropolitan Niguarda, Milan (Italy)

8 More presentations in this session

Presentation thumbnail
Orthostatic blood pressure changes and incident atrial fibrillation in patients with hypertension: Insights from the SPRINT trial
Doctor J. Wang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Diagnostic and prognostic value of ECG-predicted hypertension mediated left ventricular hypertrophy using machine learning
Doctor H. Naderi (London, GB)
Abstract Slides Video
Presentation thumbnail
Cardiac magnetic resonance (CMR) height-based allometric scaling in Southeast Asians; implications in the diagnosis and prognosis of left ventricular hypertrophy (LVH): the REMODEL study
Mr C. Lee (Dundee, GB)
Abstract Slides Video
Presentation thumbnail
Relationship between renin, aldosterone, aldosterone-to-renin ratio and left ventricular mass index in young adults
Doctor R. Ananda (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Impact of changes in left heart geometry on predicting new-onset atrial fibrillation in patients with hypertension
Assistant Professor H. KIM (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertension target organ damage

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
The incremetal predictive value of pulse wave velocity over score2 in the setting of primary cardiovascular prevention: a 6-year follow-up study
thumbnail
Congress Presentation
Pulse wave velocity progression determinants: no significant association with novel lipid parameters
thumbnail
Congress Presentation
Parallel improvement of arterial stiffness with weight loss following intensification of antidiabetic treatment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources